As of April 2, 2020, OriGen continues to remain open and maintain operations. We are able to sustain full operating shifts with additional steps taken...
Read MoreClick here for the April 2 update – OriGen Continues to Maintain Operations To: OriGen Customers and Partners OriGen Biomedical is open an...
Read MoreTo the ECMO Community: It is with the deepest regret that we have to inform you that the OriGen Reinforced Dual Lumen Catheter and other OriGen ECM...
Read MoreAustin, TX, JUNE 2019 | OriGen Biomedical is announcing a transition in leadership. Richard Martin, OriGen Founder, President and CEO, will be transit...
Read MoreOriGen is announcing a change to the Percutaneous Introducer Products. The new PCT Kit (Part Code: PCT) is designed to minimize the cut-down on the ju...
Read MoreOn August 17, 2018, OriGen Biomedical has initiated a voluntary nationwide recall of OriGen RDLC ECMO catheters. The product has been found to have ce...
Read MoreInc. Magazine has once again named OriGen Biomedical to its Inc. 5000 list of the fastest growing privately-owned companies in America for 2016, with ...
Read MoreInc. Magazine named OriGen Biomedical to its 2015 list of the fastest-growing privately-owned companies in America with a rank of #4142. Now a five-ti...
Read More